Patents Assigned to Aderegem
  • Patent number: 5635596
    Abstract: Peptides derived from the pS2 protein and polyclonal and monoclonal antibodies directed against pS2 and against pS2 fragments. Method of obtaining the secreted from of the pS2 protein and fragments thereof. Method of detecting and diagnosing different pathological conditions and especially hormone-dependent breast cancers and pathological conditions of the stomach.
    Type: Grant
    Filed: December 10, 1992
    Date of Patent: June 3, 1997
    Assignee: Aderegem
    Inventors: Pierre Chambon, Marie-Christine nee Martinet Rio, Jean-Pierre Bellocq